Table 3.

Correlation of serum glycoproteins and their fucosylated glycoforms with tumor Gleason scores in prostate cancer patients.

	Serum glycoproteins X±SE, ng/mL			Fucosylated form X±SE, ng/mL			% of Fucosylated form X±SE
	Gleason 6	Gleason 7-9	P value	Gleason 6	Gleason 7-9	P value	Gleason 6	Gleason 7-9	P value
PSA	9.32±2.14	17.59±2.82	0.1049	1.69±0.46	8.21±2.76	0.0146	16.3±1.3	34.9±5.4	0.0053
TIMP1	73.56±6.33	83.88±5.70	0.3122	26.73±2.09	24.76±2.48	0.1777	39.2±4.4	32.4±3.6	0.2357
tPA	5.20±0.76	4.67±0.33	0.9812	1.66±0.35	1.55±0.12	0.8275	34.9±5.4	33.6±1.6	0.8552

PSA: prostatic-specific antigen; TIMP1: tissue inhibitor of metallopeptidase 1; tPA: tissue plasminogen activator; Pca: prostate cancer.